174 Results

People

  1. Saltz
    Saltz
  2. Kemeny
    Kemeny
  3. Kelsen
    Kelsen
  4. Bertino
    Bertino
  5. Cohen
    Cohen
  6. O'Reilly
    O'Reilly
  7. Minsky
    Minsky
  8. Jarnagin
    Jarnagin
  9. D'Angelica
    D'Angelica
  10. Ilson
    Ilson

Groups

  1. Department of Medicine (124)
  2. Solid Tumor Oncology Division (112)
  3. Gastrointestinal Oncology Service (107)
  4. Center for Pancreatic Cancer Research (60)
  5. Surgery (39)
  6. Survivorship Research (29)
  7. Epidemiology and Biostatistics (20)
  8. Biostatistics Service (19)
  9. Population Sciences Research Program (16)
  10. Colorectal Surgery (15)
  1. "leucovorin"
Formats
  1. Journal Article (164)
  2. Meeting Abstract (3)
  3. Conference Paper (2)
  4. Review (2)
  5. Book Section (1)
  6. Editorial (1)
  7. Miscellaneous (1)
Groups
  1. Department of Medicine (124)
  2. Solid Tumor Oncology Division (112)
  3. Gastrointestinal Oncology Service (107)
  4. Center for Pancreatic Cancer Research (60)
  5. Surgery (39)
  6. Survivorship Research (29)

More Groups

People
  1. Nancy Kemeny (46)
  2. Leonard Saltz (43)
  3. David Kelsen (24)
  4. Alfred Cohen (22)
  5. Eileen O'Reilly (22)
  6. Joseph Bertino (22)

More People

Years
  1. 2025 (5)
  2. 2024 (10)
  3. 2023 (5)
  4. 2022 (7)
  5. 2020 (1)
  6. 2018 (3)

More Years

Publications
  1. Journal of Clinical Oncology (27)
  2. Cancer (18)
  3. Cancer Research (11)
  4. International Journal of Radiation Oncology, Biology, Physics (9)
  5. Annals of Oncology (8)
  6. Annals of Surgical Oncology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (28)
  2. Wiley Blackwell (26)
  3. Oxford University Press (19)
  4. Elsevier Inc. (18)
  5. American Association for Cancer Research (15)
  6. Springer (10)

More Publishers

Results (174)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A somatic BRCA2-mutated pancreatic adenocarcinoma with sustained exceptional response to modified FOLFIRINOX
    Journal Article

    Jamison, J. K.; May, M. S.; Raufi, A. G.; Luk, L.; Wong, W.; Mundi, P. S.; Manji, G. A.
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study
    Journal Article

    Theijse, R. T.; Stoop, T. F.; Janssen, Q. P.; Prakash, L. R.; Katz, M. H. G.; Doppenberg, D.; Tzeng, C. W. D.; Wei, A. C.; Zureikat, A. H.; Koerkamp, B. G.; more...
    British Journal of Surgery (2024)

    Fulltext@MSK | Save
  • Serum CEA as a prognostic marker for overall survival in patients with localized pancreatic adenocarcinoma and non-elevated CA19-9 levels treated with FOLFIRINOX as initial treatment: A TAPS consortium study
    Journal Article

    Doppenberg, D.; Stoop, T. F.; van Dieren, S.; Katz, M. H. G.; Janssen, Q. P.; Nasar, N.; Prakash, L. R.; Theijse, R. T.; Tzeng, C. W. D.; Wei, A. C.; more...
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Serum CEA as prognostic marker for overall survival in patients with localized pancreatic adenocarcinoma and nonelevated ca19-9 levels treated with FOLFIRINOX as initial treatment - A TAPS Consortium study
    Miscellaneous

    Doppenberg, D.; Stoop, T. F.; van Dieren, S.; Katz, M. H. G.; Janssen, Q. P.; Nasar, N.; Prakash, L. R.; Theijse, R. T.; Tzeng, C. W. D.; Wei, A. C.; more...
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Compliance and toxicity of total neoadjuvant therapy for rectal cancer: A secondary analysis of the OPRA trial
    Journal Article

    Verheij, F. S.; Omer, D. M.; Lin, S. T.; Yuval, J. B.; Thompson, H. M.; Kim, J. K.; Valdivieso, S. C.; Qin, L. X.; Wu, A. J.; Saltz, L. B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Modeling tumor growth using partly conditional survival models: A case study in colorectal cancer
    Journal Article

    Flynn, J. R.; Curry, M.; Zhao, B.; Yang, H.; Dercle, L.; Fojo, A. T.; Connors, D. E.; Schwartz, L. H.; Gönen, M.; Moskowitz, C. S.
    JCO Clinical Cancer Informatics (2023)

    Fulltext@MSK | Save
  • Flashback foreword: Bevacizumab and FOLFOX4 for colorectal cancer and bevacizumab versus placebo plus oxaliplatin-based chemotherapy in metastatic colorectal cancer
    Editorial

    O'Reilly, E. M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Prior irinotecan exposure does not preclude benefit to liposomal irinotecan in patients with metastatic pancreatic ductal adenocarcinoma
    Journal Article

    Yu, K. H.; Cockrum, P.; Surinach, A.; Lamarre, N.; Wang, S.; O'Reilly, E. M.
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • Treatment with liposomal irinotecan plus fluorouracil and leucovorin for patients with previously treated metastatic biliary tract cancer: The phase 2b NIFTY randomized clinical trial
    Journal Article

    Hyung, J.; Kim, I.; Kim, K. P.; Ryoo, B. Y.; Jeong, J. H.; Kang, M. J.; Cheon, J.; Kang, B. W.; Ryu, H.; Lee, J. S.; more...
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Potential mediators of oxaliplatin-induced peripheral neuropathy from adjuvant therapy in stage III colon cancer: Findings from CALGB (Alliance)/SWOG 80702
    Journal Article

    Lee, S.; Ma, C.; Shi, Q.; Kumar, P.; Couture, F.; Kuebler, P.; Krishnamurthi, S.; Lewis, D.; Tan, B.; Goldberg, R. M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save